Search

everythinglearnresearchcommunity

for

Search:↓

The DLQI is a key tool for measuring quality of life in dermatology.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Activated autologous platelet-rich plasma can improve healing in diabetic foot ulcers.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Low-dose isotretinoin and erythromycin effectively treated hair loss in two young sisters.

The 675-nm diode laser may safely help treat telogen effluvium.

Noncultured epidermal cell transplantation is effective for repigmenting stable vitiligo.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Combining red LED therapy with beta-carotene is more effective for treating photoaging than red LED therapy alone.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

The system improved diabetic wound healing in rats.

A dog with unusual skin lesions near its tail was successfully treated for a rare form of lupus.

Early diagnosis and treatment are crucial for skin emergencies and drug reactions.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Nanoparticles improve drug delivery and effectiveness in treating inflamed skin.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Higher concentrations of dithranol can help regrow hair in severe alopecia areata.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

The dual-wavelength laser system effectively reduces EFFC symptoms with minimal side effects.